{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T18:37:30Z","timestamp":1794854250549,"version":"4.9.1"},"reference-count":159,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,1,4]],"date-time":"2024-01-04T00:00:00Z","timestamp":1704326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,1,4]],"date-time":"2024-01-04T00:00:00Z","timestamp":1704326400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Headache Pain"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The World Health Organization (WHO) Intersectoral Global Action Plan on Epilepsy and Other Neurological Disorders was developed by WHO to address the worldwide challenges and gaps in provision of care and services for people with epilepsy and other neurological disorders and to ensure a comprehensive, coordinated response across sectors to the burden of neurologic diseases and to promote brain health across life-course. Headache disorders constitute the second most burdensome of all neurological diseases after stroke, but the first if young and midlife adults are taken into account. Despite the availability of a range of treatments, disability associated with headache disorders, and with migraine, remains very high. In addition, there are inequalities between high-income and low and middle income countries in access to medical care. In line with several brain health initiatives following the WHOiGAP resolution, herein we tailor the main pillars of the action plan to headache disorders: (1) raising policy prioritization and strengthen governance; (2) providing effective, timely and responsive diagnosis, treatment and care; (3) implementing strategies for promotion and prevention; (4) fostering research and innovation and strengthen information systems. Specific targets for future policy actions are proposed. The Global Action Plan triggered a revolution in neurology, not only by increasing public awareness of brain disorders and brain health but also by boosting the number of neurologists in training, raising research funding and making neurology a public health priority for policy makers. Reducing the burden of headache disorders will not only improve the quality of life and wellbeing of people with headache but also reduce the burden of neurological disorders increasing global brain health and, thus, global population health.<\/jats:p>","DOI":"10.1186\/s10194-023-01700-3","type":"journal-article","created":{"date-parts":[[2024,1,4]],"date-time":"2024-01-04T10:05:02Z","timestamp":1704362702000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":82,"title":["The World Health Organization Intersectoral Global Action Plan on Epilepsy and Other Neurological Disorders and the headache revolution: from headache burden to a global action plan for headache disorders"],"prefix":"10.1186","volume":"25","author":[{"given":"Matilde","family":"Leonardi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Martelletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rami","family":"Burstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arianna","family":"Fornari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Licia","family":"Grazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alla","family":"Guekht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard B.","family":"Lipton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimos Dimitrios","family":"Mitsikostas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes","family":"Olesen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayowa Ojo","family":"Owolabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Ruiz De la Torre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Sacco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy J.","family":"Steiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nirmal","family":"Surya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takao","family":"Takeshima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Tassorelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuu-Jiun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tissa","family":"Wijeratne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengyuan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Raggi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,4]]},"reference":[{"key":"1700_CR1","volume-title":"Intersectoral global action plan on Epilepsy and other neurological disorders 2022\u20132031","author":"World Health Organization","year":"2023","unstructured":"World Health Organization (2023) Intersectoral global action plan on Epilepsy and other neurological disorders 2022\u20132031. World Health Organization, Geneva"},{"key":"1700_CR2","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s10194-022-01420-0","volume":"23","author":"TJ Steiner","year":"2022","unstructured":"Steiner TJ, Birbeck GL, Jensen RH et al (2022) The global campaign turns 18: a brief review of its activities and achievements. J Headache Pain 23:49. https:\/\/doi.org\/10.1186\/s10194-022-01420-0","journal-title":"J Headache Pain"},{"key":"1700_CR3","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/S1474-4422(04)00703-3","volume":"3","author":"TJ Steiner","year":"2004","unstructured":"Steiner TJ, World Headache Alliance (2004) Lifting the burden: the global campaign against headache. Lancet Neurol 3:204\u2013205. https:\/\/doi.org\/10.1016\/S1474-4422(04)00703-3","journal-title":"Lancet Neurol"},{"key":"1700_CR4","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s10194-019-0993-0","volume":"20","author":"M Leonardi","year":"2019","unstructured":"Leonardi M, Raggi A (2019) A narrative review on the burden of migraine: when the burden is the impact on people\u2019s life. J Headache Pain 20:41. https:\/\/doi.org\/10.1186\/s10194-019-0993-0","journal-title":"J Headache Pain"},{"key":"1700_CR5","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","volume":"396","author":"GBD 2019 Diseases and Injuries Collaborators","year":"2020","unstructured":"GBD 2019 Diseases and Injuries Collaborators (2020) Global burden of 369 Diseases and injuries in 204 countries and territories, 1990\u20132019: a systematic analysis for the global burden of Disease Study 2019. Lancet 396:1204\u20131222","journal-title":"Lancet"},{"key":"1700_CR6","doi-asserted-by":"publisher","first-page":"e293","DOI":"10.1097\/j.pain.0000000000002275","volume":"163","author":"S Safiri","year":"2022","unstructured":"Safiri S, Pourfathi H, Eagan A et al (2022) Global, regional, and national burden of migraine in 204 countries and territories, 1990 to 2019. Pain 163:e293\u2013e309. https:\/\/doi.org\/10.1097\/j.pain.0000000000002275","journal-title":"Pain"},{"key":"1700_CR7","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1016\/S0140-6736(20)32342-4","volume":"397","author":"M Ashina","year":"2021","unstructured":"Ashina M, Buse DC, Ashina H et al (2021) Migraine: integrated approaches to clinical management and emerging treatments. Lancet 397:1505\u20131518. https:\/\/doi.org\/10.1016\/S0140-6736(20)32342-4","journal-title":"Lancet"},{"key":"1700_CR8","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.1001\/jama.2021.1640","volume":"325","author":"MS Robbins","year":"2021","unstructured":"Robbins MS (2021) Diagnosis and management of Headache: a review. JAMA 325:1874\u20131885. https:\/\/doi.org\/10.1001\/jama.2021.1640","journal-title":"JAMA"},{"key":"1700_CR9","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1038\/s41572-021-00328-4","volume":"8","author":"MD Ferrari","year":"2022","unstructured":"Ferrari MD, Goadsby PJ, Burstein R et al (2022) Migraine. Nat Rev Dis Primers 8:2. https:\/\/doi.org\/10.1038\/s41572-021-00328-4","journal-title":"Nat Rev Dis Primers"},{"key":"1700_CR10","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.ncl.2019.07.006","volume":"37","author":"SJ Tepper","year":"2019","unstructured":"Tepper SJ (2019) Acute Treatment of Migraine. Neurol Clin 37:727\u2013742. https:\/\/doi.org\/10.1016\/j.ncl.2019.07.006","journal-title":"Neurol Clin"},{"key":"1700_CR11","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1212\/CON.0000000000000956","volume":"27","author":"J Ailani","year":"2021","unstructured":"Ailani J (2021) Acute Migraine Treatment. Continuum (Minneap Minn) 27:597\u2013612. https:\/\/doi.org\/10.1212\/CON.0000000000000956","journal-title":"Continuum (Minneap Minn)"},{"key":"1700_CR12","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1212\/CON.0000000000000957","volume":"27","author":"R Burch","year":"2021","unstructured":"Burch R (2021) Preventive migraine treatment. Continuum (Minneap Minn) 27:613\u2013632. https:\/\/doi.org\/10.1212\/CON.0000000000000957","journal-title":"Continuum (Minneap Minn)"},{"key":"1700_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph18041503","volume":"18","author":"L Grazzi","year":"2021","unstructured":"Grazzi L, Toppo C, D\u2019Amico D et al (2021) Non-pharmacological approaches to Headaches: non-invasive neuromodulation, Nutraceuticals, and behavioral approaches. Int J Environ Res Public Health 18:1503. https:\/\/doi.org\/10.3390\/ijerph18041503","journal-title":"Int J Environ Res Public Health"},{"key":"1700_CR14","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s10194-021-01265-z","volume":"22","author":"TJ Steiner","year":"2021","unstructured":"Steiner TJ, Jensen R, Katsarava Z et al (2021) Structured headache services as the solution to the ill-health burden of headache: 1. Rationale and description. J Headache Pain 22:78. https:\/\/doi.org\/10.1186\/s10194-021-01265-z","journal-title":"J Headache Pain"},{"key":"1700_CR15","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s10194-021-01310-x","volume":"22","author":"M Tinelli","year":"2021","unstructured":"Tinelli M, Leonardi M, Paemeleire K et al (2021) Structured headache services as the solution to the ill-health burden of headache. 2. Modelling effectiveness and cost-effectiveness of implementation in Europe: methodology. J Headache Pain 22:99. https:\/\/doi.org\/10.1186\/s10194-021-01310-x","journal-title":"J Headache Pain"},{"key":"1700_CR16","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s10194-021-01305-8","volume":"22","author":"M Tinelli","year":"2021","unstructured":"Tinelli M, Leonardi M, Paemeleire K et al (2021) Structured headache services as the solution to the ill-health burden of headache. 3. Modelling effectiveness and cost-effectiveness of implementation in Europe: findings and conclusions. J Headache Pain 22:90. https:\/\/doi.org\/10.1186\/s10194-021-01305-8","journal-title":"J Headache Pain"},{"key":"1700_CR17","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/s10194-023-01666-2","volume":"24","author":"P Martelletti","year":"2023","unstructured":"Martelletti P, Leonardi M, Ashina M et al (2023) Rethinking headache as a global public health case model for reaching the SDG 3 HEALTH by 2030. J Headache Pain 24:140. https:\/\/doi.org\/10.1186\/s10194-023-01666-2","journal-title":"J Headache Pain"},{"key":"1700_CR18","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/s41582-023-00808-z","volume":"19","author":"MO Owolabi","year":"2023","unstructured":"Owolabi MO, Leonardi M, Bassetti C et al (2023) Global synergistic actions to improve brain health for human development. Nat Rev Neurol 19:371\u2013383. https:\/\/doi.org\/10.1038\/s41582-023-00808-z","journal-title":"Nat Rev Neurol"},{"key":"1700_CR19","volume-title":"International Classification of Functioning, disability and health","author":"World Health Organization","year":"2001","unstructured":"World Health Organization (2001) International Classification of Functioning, disability and health. World Health Organization, Geneva"},{"key":"1700_CR20","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s10194-021-01281-z","volume":"22","author":"V Caponnetto","year":"2021","unstructured":"Caponnetto V, Deodato M, Robotti M et al (2021) Comorbidities of primary headache disorders: a literature review with meta-analysis. J Headache Pain 22:71. https:\/\/doi.org\/10.1186\/s10194-021-01281-z","journal-title":"J Headache Pain"},{"issue":"10","key":"1700_CR21","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1016\/S1474-4422(19)30281-9","volume":"18","author":"T Wijeratne","year":"2019","unstructured":"Wijeratne T, Grisold W, Dodick D, Carroll W (2019) World Brain Day 2019: migraine, the painful truth. Lancet Neurol 18(10):914. https:\/\/doi.org\/10.1016\/S1474-4422(19)30281-9","journal-title":"Lancet Neurol"},{"key":"1700_CR22","doi-asserted-by":"publisher","first-page":"120720","DOI":"10.1016\/j.jns.2023.120720","volume":"451","author":"T Wijeratne","year":"2023","unstructured":"Wijeratne T, Dodick DW, Lewis SL, Guekht A, Pochigaeva K, Grisold W (2023) World Brain Day 2023 - Brain Health and disability: leave no one behind. J Neurol Sci 451:120720. https:\/\/doi.org\/10.1016\/j.jns.2023.120720","journal-title":"J Neurol Sci"},{"key":"1700_CR23","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1111\/j.1468-1331.2011.03612.x","volume":"19","author":"M Linde","year":"2012","unstructured":"Linde M, Gustavsson A, Stovner LJ et al (2012) The cost of headache disorders in Europe: the Eurolight project. Eur J Neurol 19:703\u2013711. https:\/\/doi.org\/10.1111\/j.1468-1331.2011.03612.x","journal-title":"Eur J Neurol"},{"key":"1700_CR24","doi-asserted-by":"publisher","first-page":"5717","DOI":"10.1007\/s10072-022-06164-y","volume":"43","author":"A Raggi","year":"2022","unstructured":"Raggi A, Grazzi L, Guastafierro E et al (2022) Addressing the cost of chronic and episodic migraine and its main drivers: a short-term longitudinal analysis from a third-level Italian center. Neurol Sci 43:5717\u20135724. https:\/\/doi.org\/10.1007\/s10072-022-06164-y","journal-title":"Neurol Sci"},{"key":"1700_CR25","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1080\/13696998.2022.2071528","volume":"25","author":"J Tobin","year":"2022","unstructured":"Tobin J, Ford JH, Tockhorn-Heidenreich A et al (2022) Annual indirect cost savings in patients with episodic or chronic migraine: post-hoc analyses from multiple galcanezumab clinical trials. J Med Econ 25:630\u2013639. https:\/\/doi.org\/10.1080\/13696998.2022.2071528","journal-title":"J Med Econ"},{"key":"1700_CR26","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1111\/ner.13394","volume":"24","author":"J Bulsei","year":"2021","unstructured":"Bulsei J, Leplus A, Donnet A et al (2021) Occipital nerve stimulation for refractory chronic cluster headache: a cost-effectiveness study. Neuromodulation 24:1083\u20131092. https:\/\/doi.org\/10.1111\/ner.13394","journal-title":"Neuromodulation"},{"key":"1700_CR27","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1017\/cjn.2021.75","volume":"49","author":"F Amoozegar","year":"2022","unstructured":"Amoozegar F, Khan Z, Oviedo-Ovando M, Sauriol S, Rochdi D (2022) The Burden of Illness of Migraine in Canada: New insights on Humanistic and Economic cost. Can J Neurol Sci 49:249\u2013262. https:\/\/doi.org\/10.1017\/cjn.2021.75","journal-title":"Can J Neurol Sci"},{"key":"1700_CR28","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1007\/s40273-020-00996-2","volume":"39","author":"R Mahon","year":"2021","unstructured":"Mahon R, Lang A, Vo P et al (2021) Cost-effectiveness of Erenumab for the Preventive Treatment of Migraine in patients with prior treatment failures in Sweden. Pharmacoeconomics 39:357\u2013372. https:\/\/doi.org\/10.1007\/s40273-020-00996-2","journal-title":"Pharmacoeconomics"},{"key":"1700_CR29","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s10194-020-01162-x","volume":"21","author":"A Hansson-Hedblom","year":"2020","unstructured":"Hansson-Hedblom A, Axelsson I, Jacobson L, Tedroff J, Borgstr\u00f6m F (2020) Economic consequences of migraine in Sweden and implications for the cost-effectiveness of onabotulinumtoxinA (Botox) for chronic migraine in Sweden and Norway. J Headache Pain 21:99. https:\/\/doi.org\/10.1186\/s10194-020-01162-x","journal-title":"J Headache Pain"},{"key":"1700_CR30","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1080\/14737167.2020.1768850","volume":"21","author":"P Irimia","year":"2021","unstructured":"Irimia P, Santos-Lasaosa S, Garc\u00eda Bujalance L, Ramos Pinazo L, Rubio-Rodr\u00edguez D, Rubio-Terr\u00e9s C (2021) Cost of fremanezumab, erenumab, galcanezumab and onabotulinumtoxinA associated adverse events, for migraine prophylaxis in Spain. Expert Rev Pharmacoecon Outcomes Res 21:285\u2013297. https:\/\/doi.org\/10.1080\/14737167.2020.1768850","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"key":"1700_CR31","doi-asserted-by":"publisher","first-page":"401e","DOI":"10.1097\/PRS.0000000000006480","volume":"145","author":"AR Schoenbrunner","year":"2020","unstructured":"Schoenbrunner AR, Khansa I, Janis JE (2020) Cost-effectiveness of Long-Term, targeted OnabotulinumtoxinA versus peripheral trigger site deactivation Surgery for the treatment of refractory migraine headaches. Plast Reconstr Surg 145:401e\u2013406e. https:\/\/doi.org\/10.1097\/PRS.0000000000006480","journal-title":"Plast Reconstr Surg"},{"issue":"10","key":"1700_CR32","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1007\/s40261-019-00827-z","volume":"39","author":"TV Giannouchos","year":"2019","unstructured":"Giannouchos TV, Mitsikostas DD, Ohsfeldt RL, Vozikis A, Koufopoulou P (2019) Cost-effectiveness analysis of Erenumab Versus OnabotulinumtoxinA for patients with chronic migraine Attacks in Greece. Clin Drug Investig 39(10):979\u2013990. https:\/\/doi.org\/10.1007\/s40261-019-00827-z","journal-title":"Clin Drug Investig"},{"key":"1700_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.ensci.2022.100427","volume":"29","author":"D Mortel","year":"2022","unstructured":"Mortel D, Kawatu N, Steiner TJ, Saylor D (2022) Barriers to headache care in low- and middle-income countries. eNeurologicalSci 29:100427. https:\/\/doi.org\/10.1016\/j.ensci.2022.100427","journal-title":"eNeurologicalSci"},{"issue":"1","key":"1700_CR34","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1111\/j.1526-4610.2012.02265.x","volume":"53","author":"RB Lipton","year":"2013","unstructured":"Lipton RB, Serrano D, Holland S, Fanning KM, Reed ML, Buse DC (2013) Barriers to the diagnosis and treatment of migraine: effects of sex, income, and headache features. Headache 53(1):81\u201392. https:\/\/doi.org\/10.1111\/j.1526-4610.2012.02265.x","journal-title":"Headache"},{"key":"1700_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/1129-2377-14-14","volume":"14","author":"M Viana","year":"2013","unstructured":"Viana M, Tassorelli C, Allena M, Nappi G, Sjaastad O, Antonaci F (2013) Diagnostic and therapeutic errors in trigeminal autonomic cephalalgias and hemicrania continua: a systematic review. J Headache Pain 14:14. https:\/\/doi.org\/10.1186\/1129-2377-14-14","journal-title":"J Headache Pain"},{"key":"1700_CR36","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1007\/s10194-012-0471-4","volume":"13","author":"E Cortijo","year":"2012","unstructured":"Cortijo E, Guerrero AL, Herrero S et al (2012) Hemicrania continua in a headache clinic: referral source and diagnostic delay in a series of 22 patients. J Headache Pain 13:567\u2013569. https:\/\/doi.org\/10.1007\/s10194-012-0471-4","journal-title":"J Headache Pain"},{"key":"1700_CR37","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1177\/0333102419863030","volume":"40","author":"HH Frederiksen","year":"2020","unstructured":"Frederiksen HH, Lund NL, Barloese MC, Petersen AS, Jensen RH (2020) Diagnostic delay of cluster headache: a cohort study from the Danish cluster Headache Survey. Cephalalgia 40:49\u201356. https:\/\/doi.org\/10.1177\/0333102419863030","journal-title":"Cephalalgia"},{"key":"1700_CR38","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2022.827734","volume":"13","author":"BS Kim","year":"2022","unstructured":"Kim BS, Chung PW, Kim BK et al (2022) Diagnostic Delay and its predictors in Cluster Headache. Front Neurol 13:827734. https:\/\/doi.org\/10.3389\/fneur.2022.827734","journal-title":"Front Neurol"},{"key":"1700_CR39","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1212\/wnl.58.9_suppl_6.s3","volume":"58","author":"ML Diamond","year":"2002","unstructured":"Diamond ML (2002) The role of concomitant headache types and non-headache co-morbidities in the underdiagnosis of migraine. Neurology 58:S3-9. https:\/\/doi.org\/10.1212\/wnl.58.9_suppl_6.s3","journal-title":"Neurology"},{"key":"1700_CR40","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1111\/j.1468-2982.2009.01874.x","volume":"29","author":"S Cevoli","year":"2009","unstructured":"Cevoli S, D\u2019Amico D, Martelletti P et al (2009) Underdiagnosis and undertreatment of migraine in Italy: a survey of patients attending for the first time 10 headache centres. Cephalalgia 29:1285\u20131293. https:\/\/doi.org\/10.1111\/j.1468-2982.2009.01874.x","journal-title":"Cephalalgia"},{"key":"1700_CR41","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1111\/ene.14098","volume":"27","author":"M Viana","year":"2020","unstructured":"Viana M, Khaliq F, Zecca C et al (2020) Poor patient awareness and frequent misdiagnosis of migraine: findings from a large transcontinental cohort. Eur J Neurol 27:536\u2013541. https:\/\/doi.org\/10.1111\/ene.14098","journal-title":"Eur J Neurol"},{"key":"1700_CR42","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1177\/0333102414529196","volume":"34","author":"C Arroyo-Quiroz","year":"2014","unstructured":"Arroyo-Quiroz C, Kurth T, Cantu-Brito C, Lopez-Ridaura R, Romieu I, Lajous M (2014) Lifetime prevalence and underdiagnosis of migraine in a population sample of Mexican women. Cephalalgia 34:1088\u20131092. https:\/\/doi.org\/10.1177\/0333102414529196","journal-title":"Cephalalgia"},{"issue":"6","key":"1700_CR43","doi-asserted-by":"publisher","DOI":"10.1177\/03331024231180611","volume":"43","author":"AM Adams","year":"2023","unstructured":"Adams AM, Buse DC, Leroux E (2023) Chronic Migraine Epidemiology and Outcomes - International (CaMEO-I) study: methods and multi-country baseline findings for diagnosis rates and care. Cephalalgia 43(6):3331024231180611. https:\/\/doi.org\/10.1177\/03331024231180611","journal-title":"Cephalalgia"},{"key":"1700_CR44","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1111\/head.12706","volume":"55","author":"HL O\u2019Brien","year":"2015","unstructured":"O\u2019Brien HL, Cohen JM (2015) Young adults with headaches: the transition from adolescents to adults. Headache 55:1404\u20131409. https:\/\/doi.org\/10.1111\/head.12706","journal-title":"Headache"},{"key":"1700_CR45","doi-asserted-by":"publisher","DOI":"10.1186\/1129-2377-15-15","volume":"15","author":"F Antonaci","year":"2014","unstructured":"Antonaci F, Voiticovschi-Iosob C, Di Stefano AL, Galli F, Ozge A, Balottin U (2014) The evolution of headache from childhood to adulthood: a review of the literature. J Headache Pain 15:15. https:\/\/doi.org\/10.1186\/1129-2377-15-15","journal-title":"J Headache Pain"},{"key":"1700_CR46","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/s11916-022-01042-w","volume":"26","author":"JH VanderPluym","year":"2022","unstructured":"VanderPluym JH, Charleston L 4th, Stitzer ME, Flippen CC 2, Armand CE, Kiarashi J (2022) A review of Underserved and vulnerable populations in Headache Medicine in the United States: challenges and opportunities. Curr Pain Headache Rep 26:415\u2013422. https:\/\/doi.org\/10.1007\/s11916-022-01042-w","journal-title":"Curr Pain Headache Rep"},{"key":"1700_CR47","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1111\/j.1526-4610.2010.01717.x","volume":"50","author":"ME Bigal","year":"2010","unstructured":"Bigal ME, Arruda MA (2010) Migraine in the pediatric population\u2013evolving concepts. Headache 50:1130\u20131143. https:\/\/doi.org\/10.1111\/j.1526-4610.2010.01717.x","journal-title":"Headache"},{"key":"1700_CR48","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/s10194-017-0816-0","volume":"18","author":"A Negro","year":"2017","unstructured":"Negro A, Delaruelle Z, Ivanova TA et al (2017) Headache and pregnancy: a systematic review. J Headache Pain 18:106. https:\/\/doi.org\/10.1186\/s10194-017-0816-0","journal-title":"J Headache Pain"},{"key":"1700_CR49","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.ncl.2018.09.004","volume":"37","author":"R Burch","year":"2019","unstructured":"Burch R (2019) Headache in pregnancy and the Puerperium. Neurol Clin 37:31\u201351. https:\/\/doi.org\/10.1016\/j.ncl.2018.09.004","journal-title":"Neurol Clin"},{"key":"1700_CR50","doi-asserted-by":"publisher","first-page":"2637","DOI":"10.1007\/s10072-021-05252-9","volume":"42","author":"D Pareyson","year":"2021","unstructured":"Pareyson D, Pantaleoni C, Eleopra R et al (2021) Neuro-telehealth for fragile patients in a tertiary referral neurological institute during the COVID-19 pandemic in Milan, Lombardy. Neurol Sci 42:2637\u20132644. https:\/\/doi.org\/10.1007\/s10072-021-05252-9","journal-title":"Neurol Sci"},{"key":"1700_CR51","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1007\/s10072-022-06585-9","volume":"44","author":"L Grazzi","year":"2023","unstructured":"Grazzi L, Rizzoli P, Raggi A (2023) How the COVID-19 emergency changed our modality to treat patients with migraine: a positive aspect of the pandemic. Neurol Sci 44:809\u2013810. https:\/\/doi.org\/10.1007\/s10072-022-06585-9","journal-title":"Neurol Sci"},{"key":"1700_CR52","doi-asserted-by":"publisher","first-page":"3646","DOI":"10.1007\/s00415-020-09981-3","volume":"268","author":"DL van de Graaf","year":"2021","unstructured":"van de Graaf DL, Schoonman GG, Habibovi\u0107 M, Pauws SC (2021) Towards eHealth to support the health journey of headache patients: a scoping review. J Neurol 268:3646\u20133665. https:\/\/doi.org\/10.1007\/s00415-020-09981-3","journal-title":"J Neurol"},{"key":"1700_CR53","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.2147\/JPR.S309542","volume":"14","author":"CD Noutsios","year":"2021","unstructured":"Noutsios CD, Boisvert-Plante V, Perez J, Hudon J, Ingelmo P (2021) Telemedicine applications for the evaluation of patients with Non-acute Headache: a narrative review. J Pain Res 14:1533\u20131542. https:\/\/doi.org\/10.2147\/JPR.S309542","journal-title":"J Pain Res"},{"key":"1700_CR54","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1080\/14737175.2022.2045954","volume":"22","author":"E Bentivegna","year":"2022","unstructured":"Bentivegna E, Tassorelli C, De Icco R, Sances G, Martelletti P (2022) Tele-healthcare in migraine medicine: from diagnosis to monitoring treatment outcomes. Expert Rev Neurother 22:237\u2013243. https:\/\/doi.org\/10.1080\/14737175.2022.2045954","journal-title":"Expert Rev Neurother"},{"key":"1700_CR55","doi-asserted-by":"publisher","first-page":"3795","DOI":"10.1007\/s10072-022-05910-6","volume":"43","author":"E Spina","year":"2022","unstructured":"Spina E, Tedeschi G, Russo A et al (2022) Telemedicine application to headache: a critical review. Neurol Sci 43:3795\u20133801. https:\/\/doi.org\/10.1007\/s10072-022-05910-6","journal-title":"Neurol Sci"},{"issue":"7","key":"1700_CR56","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1111\/head.14520","volume":"63","author":"RB Lipton","year":"2023","unstructured":"Lipton RB, Sico J, Seng EK (2023) Migraine screening in English and Spanish. Headache 63(7):843\u2013845. https:\/\/doi.org\/10.1111\/head.14520","journal-title":"Headache"},{"issue":"3","key":"1700_CR57","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1212\/01.wnl.0000078940.53438.83","volume":"61","author":"RB Lipton","year":"2003","unstructured":"Lipton RB, Dodick D, Sadovsky R et al (2003) A self-administered screener for migraine in primary care: the ID Migraine validation study. Neurology 61(3):375\u2013382. https:\/\/doi.org\/10.1212\/01.wnl.0000078940.53438.83","journal-title":"Neurology"},{"issue":"5","key":"1700_CR58","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgph.0000196","volume":"2","author":"J Bigio","year":"2022","unstructured":"Bigio J, MacLean E, Vasquez NA et al (2022) Most common reasons for primary care visits in low- and middle-income countries: a systematic review. PLOS Glob Public Health 2(5):e0000196. https:\/\/doi.org\/10.1371\/journal.pgph.0000196","journal-title":"PLOS Glob Public Health"},{"issue":"11","key":"1700_CR59","first-page":"832","volume":"64","author":"CR Finley","year":"2018","unstructured":"Finley CR, Chan DS, Garrison S et al (2018) What are the most common conditions in primary care? Systematic review. Can Fam Physician 64(11):832\u2013840","journal-title":"Can Fam Physician"},{"issue":"8","key":"1700_CR60","doi-asserted-by":"publisher","DOI":"10.1177\/03331024231194024","volume":"43","author":"A Evlice","year":"2023","unstructured":"Evlice A, Gen\u00e7 H, Uluduz D et al (2023) Secondary headache disorders in Turkey, the Middle East, Asia, and Africa: a cross-sectional, multicenter study. Cephalalgia 43(8):3331024231194024. https:\/\/doi.org\/10.1177\/03331024231194024","journal-title":"Cephalalgia"},{"key":"1700_CR61","doi-asserted-by":"publisher","unstructured":"Headache Classification Committee of the International Headache Society (IHS) (2018) The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 38:1-211. https:\/\/doi.org\/10.1177\/0333102417738202","DOI":"10.1177\/0333102417738202"},{"key":"1700_CR62","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.mcna.2018.10.003","volume":"103","author":"R Burch","year":"2019","unstructured":"Burch R (2019) Migraine and tension-type headache: diagnosis and treatment. Med Clin North Am 103:215\u2013233. https:\/\/doi.org\/10.1016\/j.mcna.2018.10.003","journal-title":"Med Clin North Am"},{"key":"1700_CR63","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/s41582-021-00509-5","volume":"17","author":"AK Eigenbrodt","year":"2021","unstructured":"Eigenbrodt AK, Ashina H, Khan S et al (2021) Diagnosis and management of migraine in ten steps. Nat Rev Neurol 17:501\u2013514. https:\/\/doi.org\/10.1038\/s41582-021-00509-5","journal-title":"Nat Rev Neurol"},{"key":"1700_CR64","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s11910-021-01114-1","volume":"21","author":"H Suri","year":"2021","unstructured":"Suri H, Ailani J (2021) Cluster headache: a review and update in treatment. Curr Neurol Neurosci Rep 21:31. https:\/\/doi.org\/10.1007\/s11910-021-01114-1","journal-title":"Curr Neurol Neurosci Rep"},{"key":"1700_CR65","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s11916-021-00989-6","volume":"25","author":"S Evers","year":"2021","unstructured":"Evers S, Summ O (2021) Neurostimulation Treatment in Chronic Cluster Headache-a narrative review. Curr Pain Headache Rep 25:81. https:\/\/doi.org\/10.1007\/s11916-021-00989-6","journal-title":"Curr Pain Headache Rep"},{"key":"1700_CR66","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1007\/s10143-021-01725-9","volume":"45","author":"A Franzini","year":"2022","unstructured":"Franzini A, Clerici E, Navarria P, Picozzi P (2022) Gamma Knife radiosurgery for the treatment of cluster headache: a systematic review. Neurosurg Rev 45:1923\u20131931. https:\/\/doi.org\/10.1007\/s10143-021-01725-9","journal-title":"Neurosurg Rev"},{"key":"1700_CR67","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/head.12695","volume":"56","author":"MS Robbins","year":"2016","unstructured":"Robbins MS, Robertson CE, Ailani J, Levin M, Friedman DI, Dodick DW (2016) Procedural Headache Medicine in Neurology Residency Training: a Survey of US Program directors. Headache 56:79\u201385. https:\/\/doi.org\/10.1111\/head.12695","journal-title":"Headache"},{"key":"1700_CR68","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1111\/head.12803","volume":"56","author":"M Minen","year":"2016","unstructured":"Minen M, Shome A, Halpern A et al (2016) A migraine management training program for primary care providers: an overview of a survey and pilot study findings, lessons learned, and considerations for further research. Headache 56:725\u2013740. https:\/\/doi.org\/10.1111\/head.12803","journal-title":"Headache"},{"key":"1700_CR69","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1111\/head.12822","volume":"56","author":"ZA Ahmed","year":"2016","unstructured":"Ahmed ZA, Faulkner LR (2016) Headache Education in Adult Neurology Residency: a Survey of Program directors and Chief residents. Headache 56:871\u2013877. https:\/\/doi.org\/10.1111\/head.12822","journal-title":"Headache"},{"key":"1700_CR70","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1111\/head.13110","volume":"57","author":"JJY Ong","year":"2017","unstructured":"Ong JJY, Chan YC (2017) Medical undergraduate survey on Headache Education in Singapore: knowledge, perceptions, and Assessment of Unmet needs. Headache 57:967\u2013978. https:\/\/doi.org\/10.1111\/head.13110","journal-title":"Headache"},{"key":"1700_CR71","doi-asserted-by":"publisher","first-page":"2223","DOI":"10.1007\/s10072-018-3540-x","volume":"39","author":"V Raieli","year":"2018","unstructured":"Raieli V, Loiacono C, Messina LM, Correnti E, Brighina F (2018) Is a digital platform useful in headache training? A 4-year Italian experience. Neurol Sci 39:2223\u20132224. https:\/\/doi.org\/10.1007\/s10072-018-3540-x","journal-title":"Neurol Sci"},{"key":"1700_CR72","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1111\/head.14134","volume":"61","author":"A Pace","year":"2021","unstructured":"Pace A, Orr SL, Rosen NL, Safdieh JE, Cruz GB, Sprouse-Blum AS (2021) The current state of headache medicine education in the United States and Canada: an observational, survey-based study of neurology clerkship directors and curriculum deans. Headache 61:854\u2013862. https:\/\/doi.org\/10.1111\/head.14134","journal-title":"Headache"},{"key":"1700_CR73","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1186\/s12909-022-03299-6","volume":"22","author":"TP Do","year":"2022","unstructured":"Do TP, D\u00f8mgaard M, Stefansen S, Kristoffersen ES, Ashina M, Hansen JM (2022) Barriers and gaps in headache education: a national cross-sectional survey of neurology residents in Denmark. BMC Med Educ 22:233. https:\/\/doi.org\/10.1186\/s12909-022-03299-6","journal-title":"BMC Med Educ"},{"key":"1700_CR74","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s11916-020-00915-2","volume":"24","author":"M Marzouk","year":"2021","unstructured":"Marzouk M, Seng EK (2021) The impact of parental migraine on children. Curr Pain Headache Rep 24:81. https:\/\/doi.org\/10.1007\/s11916-020-00915-2","journal-title":"Curr Pain Headache Rep"},{"key":"1700_CR75","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1111\/head.13028","volume":"57","author":"RB Lipton","year":"2017","unstructured":"Lipton RB, Buse DC, Adams AM, Varon SF, Fanning KM, Reed ML (2017) Family Impact of Migraine: development of the impact of Migraine on partners and adolescent children (IMPAC) scale. Headache 57:570\u2013585. https:\/\/doi.org\/10.1111\/head.13028","journal-title":"Headache"},{"key":"1700_CR76","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.mayocp.2016.02.013","volume":"91","author":"DC Buse","year":"2016","unstructured":"Buse DC, Scher AI, Dodick DW et al (2016) Impact of Migraine on the Family: Perspectives of People With Migraine and Their Spouse\/Domestic Partner in the CaMEO Study. Mayo Clin Proc 91:596\u2013611. https:\/\/doi.org\/10.1016\/j.mayocp.2016.02.013","journal-title":"Mayo Clin Proc"},{"key":"1700_CR77","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1007\/s10194-012-0441-x","volume":"13","author":"MA Arruda","year":"2012","unstructured":"Arruda MA, Bigal ME (2012) Migraine and behavior in children: influence of maternal headache frequency. J Headache Pain 13:395\u2013400. https:\/\/doi.org\/10.1007\/s10194-012-0441-x","journal-title":"J Headache Pain"},{"key":"1700_CR78","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1111\/head.13711","volume":"60","author":"H Pohl","year":"2020","unstructured":"Pohl H, Gantenbein AR, Sandor PS, Schoenen J, Andr\u00e9e C (2020) Interictal burden of Cluster Headache: results of the EUROLIGHT Cluster Headache Project, an Internet-Based, cross-sectional study of people with cluster headache. Headache 60:360\u2013369. https:\/\/doi.org\/10.1111\/head.13711","journal-title":"Headache"},{"key":"1700_CR79","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1111\/head.13613","volume":"59","author":"DC Buse","year":"2019","unstructured":"Buse DC, Fanning KM, Reed ML et al (2019) Life with Migraine: effects on relationships, Career, and Finances from the chronic migraine epidemiology and outcomes (CaMEO) study. Headache 59:1286\u20131299. https:\/\/doi.org\/10.1111\/head.13613","journal-title":"Headache"},{"key":"1700_CR80","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1111\/head.13254","volume":"58","author":"DC Buse","year":"2018","unstructured":"Buse DC, Powers SW, Gelfand AA et al (2018) Adolescent perspectives on the Burden of a parent\u2019s migraine: results from the CaMEO study. Headache 58:512\u2013524. https:\/\/doi.org\/10.1111\/head.13254","journal-title":"Headache"},{"key":"1700_CR81","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1111\/head.13433","volume":"59","author":"EK Seng","year":"2019","unstructured":"Seng EK, Mauser ED, Marzouk M, Patel ZS, Rosen N, Buse DC (2019) When Mom has Migraine: an observational study of the impact of parental migraine on adolescent children. Headache 59:224\u2013234. https:\/\/doi.org\/10.1111\/head.13433","journal-title":"Headache"},{"key":"1700_CR82","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1111\/head.13822","volume":"60","author":"G Natalucci","year":"2020","unstructured":"Natalucci G, Faedda N, Baglioni V, Guidetti V (2020) The relationship between parental Care and Pain in Children with Headache: a narrative review. Headache 60:1217\u20131224. https:\/\/doi.org\/10.1111\/head.13822","journal-title":"Headache"},{"key":"1700_CR83","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/nrneurol.2016.93","volume":"12","author":"A May","year":"2016","unstructured":"May A, Schulte LH (2016) Chronic migraine: risk factors, mechanisms and treatment. Nat Rev Neurol 12:455\u2013464. https:\/\/doi.org\/10.1038\/nrneurol.2016.93","journal-title":"Nat Rev Neurol"},{"key":"1700_CR84","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/nrneurol.2016.124","volume":"12","author":"HC Diener","year":"2016","unstructured":"Diener HC, Holle D, Solbach K, Gaul C (2016) Medication-overuse headache: risk factors, pathophysiology and management. Nat Rev Neurol 12:575\u2013583. https:\/\/doi.org\/10.1038\/nrneurol.2016.124","journal-title":"Nat Rev Neurol"},{"key":"1700_CR85","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1007\/s11916-014-0465-9","volume":"19","author":"SJ Cho","year":"2015","unstructured":"Cho SJ, Chu MK (2015) Risk factors of chronic daily headache or chronic migraine. Curr Pain Headache Rep 19:465. https:\/\/doi.org\/10.1007\/s11916-014-0465-9","journal-title":"Curr Pain Headache Rep"},{"key":"1700_CR86","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1177\/0333102420977183","volume":"41","author":"S Schramm","year":"2021","unstructured":"Schramm S, Tenhagen I, Schmidt B et al (2021) Prevalence and risk factors of migraine and non-migraine headache in older people - results of the Heinz Nixdorf Recall study. Cephalalgia 41:649\u2013664. https:\/\/doi.org\/10.1177\/0333102420977183","journal-title":"Cephalalgia"},{"issue":"156\u201362","key":"1700_CR87","doi-asserted-by":"publisher","first-page":"e10","DOI":"10.1111\/ene.12547","volume":"22","author":"CF Fagern\u00e6s","year":"2015","unstructured":"Fagern\u00e6s CF, Heuch I, Zwart JA, Winsvold BS, Linde M, Hagen K (2015) Blood pressure as a risk factor for headache and migraine: a prospective population-based study. Eur J Neurol 22(156\u201362):e10-11. https:\/\/doi.org\/10.1111\/ene.12547","journal-title":"Eur J Neurol"},{"key":"1700_CR88","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.19294","volume":"13","author":"ASA Elbadawi","year":"2021","unstructured":"Elbadawi ASA, Albalawi AFA, Alghannami AK et al (2021) Cluster headache and Associated Risk factors: a systemic review and Meta-analysis. Cureus 13:e19294. https:\/\/doi.org\/10.7759\/cureus.19294","journal-title":"Cureus"},{"key":"1700_CR89","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s10194-020-1075-z","volume":"21","author":"W Xie","year":"2020","unstructured":"Xie W, Li R, He M et al (2020) Prevalence and risk factors associated with headache amongst medical staff in South China. J Headache Pain 21:5. https:\/\/doi.org\/10.1186\/s10194-020-1075-z","journal-title":"J Headache Pain"},{"key":"1700_CR90","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1111\/ane.13014","volume":"138","author":"D D\u2019Amico","year":"2018","unstructured":"D\u2019Amico D, Sansone E, Grazzi L et al (2018) Multimorbidity in patients with chronic migraine and medication overuse headache. Acta Neurol Scand 138:515\u2013522. https:\/\/doi.org\/10.1111\/ane.13014","journal-title":"Acta Neurol Scand"},{"key":"1700_CR91","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph17228549","volume":"17","author":"FH Kuo","year":"2020","unstructured":"Kuo FH, Lee CY, Li JP et al (2020) Migraine as a risk factor for peripheral artery occlusive Disease: a Population-based Cohort Study. Int J Environ Res Public Health 17:8549. https:\/\/doi.org\/10.3390\/ijerph17228549","journal-title":"Int J Environ Res Public Health"},{"key":"1700_CR92","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1177\/0333102415576222","volume":"35","author":"AA Gelfand","year":"2015","unstructured":"Gelfand AA, Fullerton HJ, Jacobson A et al (2015) Is migraine a risk factor for pediatric Stroke? Cephalalgia 35:1252\u20131260. https:\/\/doi.org\/10.1177\/0333102415576222","journal-title":"Cephalalgia"},{"key":"1700_CR93","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.20202","volume":"13","author":"M Hassan","year":"2021","unstructured":"Hassan M, Belavadi R, Gudigopuram SVR et al (2021) Migraine and Stroke: in search of Shared pathways, mechanisms, and risk factors. Cureus 13:e20202. https:\/\/doi.org\/10.7759\/cureus.20202","journal-title":"Cureus"},{"key":"1700_CR94","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1111\/ene.13060","volume":"23","author":"J Norton","year":"2016","unstructured":"Norton J, Portet F, Gabelle A et al (2016) Are migraine and non-migrainous headache risk factors for Stroke in the elderly? Findings from a 12-year cohort follow-up. Eur J Neurol 23:1463\u20131470. https:\/\/doi.org\/10.1111\/ene.13060","journal-title":"Eur J Neurol"},{"key":"1700_CR95","doi-asserted-by":"publisher","DOI":"10.1016\/j.clineuro.2020.106375","volume":"200","author":"G Tekgol Uzuner","year":"2021","unstructured":"Tekgol Uzuner G, Yal\u0131n OO, Uluduz D, Ozge A, Uzuner N (2021) Migraine and cardiovascular risk factors: a clinic-based study. Clin Neurol Neurosurg 200:106375. https:\/\/doi.org\/10.1016\/j.clineuro.2020.106375","journal-title":"Clin Neurol Neurosurg"},{"key":"1700_CR96","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.119.014546","volume":"8","author":"IY Elgendy","year":"2019","unstructured":"Elgendy IY, Nadeau SE, Bairey Merz CN et al (2019) Migraine Headache: an under-appreciated risk factor for Cardiovascular Disease in Women. J Am Heart Assoc 8:e014546. https:\/\/doi.org\/10.1161\/JAHA.119.014546","journal-title":"J Am Heart Assoc"},{"key":"1700_CR97","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1001\/jama.2020.7172","volume":"323","author":"T Kurth","year":"2020","unstructured":"Kurth T, Rist PM, Ridker PM, Kotler G, Bubes V, Buring JE (2020) Association of Migraine with Aura and other risk factors with Incident Cardiovascular Disease in Women. JAMA 323:2281\u20132289. https:\/\/doi.org\/10.1001\/jama.2020.7172","journal-title":"JAMA"},{"key":"1700_CR98","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1111\/head.14213","volume":"61","author":"A Klein","year":"2021","unstructured":"Klein A, Schankin CJ (2021) Visual snow syndrome, the spectrum of perceptual disorders, and migraine as a common risk factor: a narrative review. Headache 61:1306\u20131313. https:\/\/doi.org\/10.1111\/head.14213","journal-title":"Headache"},{"key":"1700_CR99","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/j.jad.2021.08.119","volume":"295","author":"NZ Welander","year":"2021","unstructured":"Welander NZ, Mwinyi J, Asif S, Schi\u00f6th HB, Skalkidou A, Fransson E (2021) Migraine as a risk factor for mixed symptoms of peripartum depression and anxiety in late pregnancy: a prospective cohort study. J Affect Disord 295:733\u2013739. https:\/\/doi.org\/10.1016\/j.jad.2021.08.119","journal-title":"J Affect Disord"},{"key":"1700_CR100","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s10194-020-01108-3","volume":"21","author":"D Guido","year":"2020","unstructured":"Guido D, Leonardi M, Mellor-Mars\u00e1 B et al (2020) Pain rates in general population for the period 1991\u20132015 and 10-years prediction: results from a multi-continent age-period-cohort analysis. J Headache Pain 21:52. https:\/\/doi.org\/10.1186\/s10194-020-01108-3","journal-title":"J Headache Pain"},{"key":"1700_CR101","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s10194-020-01116-3","volume":"21","author":"A Raggi","year":"2020","unstructured":"Raggi A, Leonardi M, Mellor-Mars\u00e1 B et al (2020) Predictors of pain in general ageing populations: results from a multi-country analysis based on ATHLOS harmonized database. J Headache Pain 21:45. https:\/\/doi.org\/10.1186\/s10194-020-01116-3","journal-title":"J Headache Pain"},{"key":"1700_CR102","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1093\/ije\/dyaa236","volume":"50","author":"A Sanchez-Niubo","year":"2021","unstructured":"Sanchez-Niubo A, Forero CG, Wu YT et al (2021) Development of a common scale for measuring healthy ageing across the world: results from the ATHLOS consortium. Int J Epidemiol 50:880\u2013892. https:\/\/doi.org\/10.1093\/ije\/dyaa236","journal-title":"Int J Epidemiol"},{"key":"1700_CR103","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s10194-023-01630-0","volume":"24","author":"L Grazzi","year":"2023","unstructured":"Grazzi L, D\u2019Amico D, Guastafierro E et al (2023) Efficacy of mindfulness added to treatment as usual in patients with chronic migraine and medication overuse headache: a phase-III single-blind randomized-controlled trial (the MIND-CM study). J Headache Pain 24:86. https:\/\/doi.org\/10.1186\/s10194-023-01630-0","journal-title":"J Headache Pain"},{"key":"1700_CR104","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1111\/ane.13475","volume":"144","author":"D D\u2019Amico","year":"2021","unstructured":"D\u2019Amico D, Grazzi L, Guastafierro E, Sansone E, Leonardi M, Raggi A (2021) Withdrawal failure in patients with chronic migraine and medication overuse headache. Acta Neurol Scand 144:408\u2013417. https:\/\/doi.org\/10.1111\/ane.13475","journal-title":"Acta Neurol Scand"},{"key":"1700_CR105","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/S1474-4422(18)30387-9","volume":"17","author":"GBD 2016 Meningitis Collaborators","year":"2018","unstructured":"GBD 2016 Meningitis Collaborators (2018) Global, regional, and national burden of Meningitis, 1990\u20132016: a systematic analysis for the global burden of Disease Study 2016. Lancet Neurol 17:1061\u20131082. https:\/\/doi.org\/10.1016\/S1474-4422(18)30387-9","journal-title":"Lancet Neurol"},{"key":"1700_CR106","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/S1474-4422(18)30499-X","volume":"18","author":"GBD 2016 Neurology Collaborators","year":"2019","unstructured":"GBD 2016 Neurology Collaborators (2019) Global, regional, and national burden of neurological disorders, 1990\u20132016: a systematic analysis for the global burden of Disease Study 2016. Lancet Neurol 18:459\u2013480. https:\/\/doi.org\/10.1016\/S1474-4422(18)30499-X","journal-title":"Lancet Neurol"},{"key":"1700_CR107","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1136\/jnnp-2019-320466","volume":"91","author":"A Raggi","year":"2020","unstructured":"Raggi A, Leonardi M (2020) Burden of brain disorders in Europe in 2017 and comparison with other non-communicable Disease groups. J Neurol Neurosurg Psychiatry 91:104\u2013105. https:\/\/doi.org\/10.1136\/jnnp-2019-320466","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1700_CR108","doi-asserted-by":"publisher","first-page":"2080","DOI":"10.1007\/s00415-021-10774-5","volume":"269","author":"A Raggi","year":"2022","unstructured":"Raggi A, Monasta L, Beghi E et al (2022) Incidence, prevalence and disability associated with neurological disorders in Italy between 1990 and 2019: an analysis based on the global burden of Disease Study 2019. J Neurol 269:2080\u20132098. https:\/\/doi.org\/10.1007\/s00415-021-10774-5","journal-title":"J Neurol"},{"key":"1700_CR109","doi-asserted-by":"publisher","first-page":"3820","DOI":"10.1111\/ene.15040","volume":"28","author":"C Fern\u00e1ndez-de-Las-Pe\u00f1as","year":"2021","unstructured":"Fern\u00e1ndez-de-Las-Pe\u00f1as C, Navarro-Santana M, G\u00f3mez-Mayordomo V et al (2021) Headache as an acute and post-COVID-19 symptom in COVID-19 survivors: a meta-analysis of the current literature. Eur J Neurol 28:3820\u20133825. https:\/\/doi.org\/10.1111\/ene.15040","journal-title":"Eur J Neurol"},{"key":"1700_CR110","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s10194-022-01400-4","volume":"23","author":"M Castaldo","year":"2022","unstructured":"Castaldo M, Waliszewska-Pros\u00f3\u0142 M, Koutsokera M et al (2022) Headache onset after vaccination against SARS-CoV-2: a systematic literature review and meta-analysis. J Headache Pain 23:41. https:\/\/doi.org\/10.1186\/s10194-022-01400-4","journal-title":"J Headache Pain"},{"issue":"3","key":"1700_CR111","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1097\/WCO.0000000000001153","volume":"36","author":"C Tana","year":"2023","unstructured":"Tana C, Giamberardino MA, Martelletti P (2023) Long COVID and especially headache syndromes. Curr Opin Neurol 36(3):168\u2013174. https:\/\/doi.org\/10.1097\/WCO.0000000000001153","journal-title":"Curr Opin Neurol"},{"key":"1700_CR112","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1007\/s42399-021-00964-7","volume":"3","author":"P Martelletti","year":"2021","unstructured":"Martelletti P, Bentivegna E, Spuntarelli V, Luciani M (2021) Long-COVID headache. SN Compr Clin Med 3:1704\u20131706. https:\/\/doi.org\/10.1007\/s42399-021-00964-7","journal-title":"SN Compr Clin Med"},{"key":"1700_CR113","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8111921","volume":"8","author":"DC Voormolen","year":"2019","unstructured":"Voormolen DC, Haagsma JA, Polinder S et al (2019) Post-concussion symptoms in complicated vs. Uncomplicated Mild Traumatic Brain Injury Patients at Three and Six Months Post-Injury: Results from the CENTER-TBI Study. J Clin Med Res 8:1921. https:\/\/doi.org\/10.3390\/jcm8111921","journal-title":"J Clin Med Res"},{"key":"1700_CR114","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1111\/j.1468-2982.2008.01577.x","volume":"28","author":"K Aaseth","year":"2008","unstructured":"Aaseth K, Grande RB, Kv\u00e1rner KJ, Gulbrandsen P, Lundqvist C, Russell MB (2008) Prevalence of secondary chronic headaches in a Population-based sample of 30-44-year-old persons. The Akershus Study of Chronic Headache. Cephalalgia 28:705\u2013713. https:\/\/doi.org\/10.1111\/j.1468-2982.2008.01577.x","journal-title":"Cephalalgia"},{"key":"1700_CR115","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1212\/wnl.42.6.1225","volume":"42","author":"BK Rasmussen","year":"1992","unstructured":"Rasmussen BK, Olesen J (1992) Symptomatic and nonsymptomatic headaches in a general population. Neurology 42:1225\u20131231. https:\/\/doi.org\/10.1212\/wnl.42.6.1225","journal-title":"Neurology"},{"key":"1700_CR116","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s10194-020-01135-0","volume":"21","author":"S Benemei","year":"2020","unstructured":"Benemei S, Labastida-Ram\u00edrez A, Abramova E et al (2020) Persistent post-traumatic headache: a migrainous loop or not? The preclinical evidence. J Headache Pain 21:90. https:\/\/doi.org\/10.1186\/s10194-020-01135-0","journal-title":"J Headache Pain"},{"key":"1700_CR117","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1111\/head.12620","volume":"55","author":"FR Taylor","year":"2015","unstructured":"Taylor FR (2015) Tobacco, Nicotine, and Headache. Headache 55:1028\u20131044. https:\/\/doi.org\/10.1111\/head.12620","journal-title":"Headache"},{"key":"1700_CR118","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1111\/head.13295","volume":"58","author":"TD Rozen","year":"2018","unstructured":"Rozen TD (2018) Cluster headache clinical phenotypes: Tobacco Nonexposed (never smoker and no parental secondary smoke exposure as a child) versus Tobacco-Exposed: results from the United States Cluster Headache Survey. Headache 58:688\u2013699. https:\/\/doi.org\/10.1111\/head.13295","journal-title":"Headache"},{"key":"1700_CR119","doi-asserted-by":"publisher","unstructured":"Friedman DI, De ver Dye T (2009) Migraine and the environment. Headache. 49:941\u2009\u2013\u200952. https:\/\/doi.org\/10.1111\/j.1526-4610.2009.01443.x","DOI":"10.1111\/j.1526-4610.2009.01443.x"},{"key":"1700_CR120","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1097\/WCO.0000000000001065","volume":"35","author":"D Martinelli","year":"2022","unstructured":"Martinelli D, Pocora MM, De Icco R, Putort\u00ec A, Tassorelli C (2022) Triggers of migraine: where do we stand? Curr Opin Neurol 35:360\u2013366. https:\/\/doi.org\/10.1097\/WCO.0000000000001065","journal-title":"Curr Opin Neurol"},{"key":"1700_CR121","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s10194-021-01243-5","volume":"22","author":"T Shimizu","year":"2021","unstructured":"Shimizu T, Sakai F, Miyake H et al (2021) Disability, quality of life, productivity impairment and employer costs of migraine in the workplace. J Headache Pain 22:29. https:\/\/doi.org\/10.1186\/s10194-021-01243-5","journal-title":"J Headache Pain"},{"key":"1700_CR122","doi-asserted-by":"publisher","unstructured":"Raggi A, Leonardi M, Sansone E, Curone M, Grazzi L, D\u2019Amico D (2020) The cost and the value of treatment of medication overuse headache in Italy: a longitudinal study based on patient-derived data. Eur J Neurol 27:62\u2013e1. https:\/\/doi.org\/10.1111\/ene.14034","DOI":"10.1111\/ene.14034"},{"key":"1700_CR123","doi-asserted-by":"publisher","DOI":"10.1016\/j.ensci.2022.100408","volume":"27","author":"O de Begasse","year":"2022","unstructured":"de Begasse O, Sakai F (2022) Migraine in the workplace. eNeurologicalSci 27:100408. https:\/\/doi.org\/10.1016\/j.ensci.2022.100408","journal-title":"eNeurologicalSci"},{"key":"1700_CR124","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1111\/head.12994","volume":"57","author":"GE Tietjen","year":"2017","unstructured":"Tietjen GE, Karmakar M, Amialchuk AA (2017) Emotional abuse history and migraine among young adults: a retrospective cross-sectional analysis of the add Health dataset. Headache 57:45\u201359. https:\/\/doi.org\/10.1111\/head.12994","journal-title":"Headache"},{"key":"1700_CR125","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1111\/j.1526-4610.2009.01557.x","volume":"50","author":"GE Tietjen","year":"2010","unstructured":"Tietjen GE, Brandes JL, Peterlin BL et al (2010) Childhood maltreatment and migraine (part II). Emotional abuse as a risk factor for headache chronification. Headache 50:32\u201341. https:\/\/doi.org\/10.1111\/j.1526-4610.2009.01557.x","journal-title":"Headache"},{"key":"1700_CR126","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1212\/WNL.0000000000001120","volume":"84","author":"GE Tietjen","year":"2015","unstructured":"Tietjen GE, Buse DC, Fanning KM, Serrano D, Reed ML, Lipton RB (2015) Recalled maltreatment, migraine, and tension-type headache: results of the AMPP study. Neurology 84:132\u2013140. https:\/\/doi.org\/10.1212\/WNL.0000000000001120","journal-title":"Neurology"},{"issue":"1","key":"1700_CR127","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1111\/j.1468-2982.2004.00643.x","volume":"24","author":"KD Juang","year":"2004","unstructured":"Juang KD, Wang SJ, Fuh JL, Lu SR, Chen YS (2004) Association between adolescent chronic daily headache and childhood adversity: a community-based study. Cephalalgia 24(1):54\u201359. https:\/\/doi.org\/10.1111\/j.1468-2982.2004.00643.x","journal-title":"Cephalalgia"},{"key":"1700_CR128","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1111\/j.1526-4610.2009.01339.x","volume":"49","author":"U I\u015fik","year":"2009","unstructured":"I\u015fik U, Topuzo\u011flu A, Ay P et al (2009) The prevalence of headache and its association with socioeconomic status among schoolchildren in Istanbul. Turk Headache 49:697\u2013703. https:\/\/doi.org\/10.1111\/j.1526-4610.2009.01339.x","journal-title":"Turk Headache"},{"key":"1700_CR129","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1212\/01.wnl.0000265212.90735.64","volume":"69","author":"ME Bigal","year":"2007","unstructured":"Bigal ME, Lipton RB, Winner P et al (2007) Migraine in adolescents: association with socioeconomic status and family history. Neurology 69:16\u201325. https:\/\/doi.org\/10.1212\/01.wnl.0000265212.90735.64","journal-title":"Neurology"},{"key":"1700_CR130","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1111\/j.1526-4610.2005.05006.x","volume":"45","author":"HT Atasoy","year":"2005","unstructured":"Atasoy HT, Unal AE, Atasoy N, Emre U, Sumer M (2005) Low income and education levels may cause medication overuse and chronicity in migraine patients. Headache 45:25\u201331. https:\/\/doi.org\/10.1111\/j.1526-4610.2005.05006.x","journal-title":"Headache"},{"key":"1700_CR131","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1177\/0333102414541817","volume":"34","author":"V Guidetti","year":"2014","unstructured":"Guidetti V, Dosi C, Bruni O (2014) The relationship between sleep and headache in children: implications for treatment. Cephalalgia 34:767\u2013776. https:\/\/doi.org\/10.1177\/0333102414541817","journal-title":"Cephalalgia"},{"key":"1700_CR132","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.spen.2015.04.005","volume":"22","author":"C Dosi","year":"2015","unstructured":"Dosi C, Figura M, Ferri R, Bruni O (2015) Sleep and headache. Semin Pediatr Neurol. 22:105\u2013112. https:\/\/doi.org\/10.1016\/j.spen.2015.04.005","journal-title":"Semin Pediatr Neurol."},{"key":"1700_CR133","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1111\/j.1468-2982.2009.01907.x","volume":"30","author":"ST Kinik","year":"2010","unstructured":"Kinik ST, Alehan F, Erol I, Kanra AR (2010) Obesity and paediatric migraine. Cephalalgia 30:105\u2013109. https:\/\/doi.org\/10.1111\/j.1468-2982.2009.01907.x","journal-title":"Cephalalgia"},{"key":"1700_CR134","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/420858","volume":"2014","author":"A Verrotti","year":"2014","unstructured":"Verrotti A, Di Fonzo A, Penta L, Agostinelli S, Parisi P (2014) Obesity and headache\/migraine: the importance of weight reduction through lifestyle modifications. Biomed Res Int 2014:420858. https:\/\/doi.org\/10.1155\/2014\/420858","journal-title":"Biomed Res Int"},{"key":"1700_CR135","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1177\/0883073808327831","volume":"24","author":"TM Lateef","year":"2009","unstructured":"Lateef TM, Merikangas KR, He J et al (2009) Headache in a national sample of American children: prevalence and comorbidity. J Child Neurol 24:536\u2013543. https:\/\/doi.org\/10.1177\/0883073808327831","journal-title":"J Child Neurol"},{"key":"1700_CR136","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1111\/j.1469-8749.2010.03793.x","volume":"52","author":"I Abu-Arafeh","year":"2010","unstructured":"Abu-Arafeh I, Razak S, Sivaraman B, Graham C (2010) Prevalence of headache and migraine in children and adolescents: a systematic review of population-based studies. Dev Med Child Neurol 52:1088\u20131097. https:\/\/doi.org\/10.1111\/j.1469-8749.2010.03793.x","journal-title":"Dev Med Child Neurol"},{"key":"1700_CR137","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/S1474-4422(18)30434-4","volume":"18","author":"M Ashina","year":"2019","unstructured":"Ashina M (2019) The most important advances in headache research in 2018. Lancet Neurol 18:5\u20136. https:\/\/doi.org\/10.1016\/S1474-4422(18)30434-4","journal-title":"Lancet Neurol"},{"key":"1700_CR138","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/S1474-4422(20)30457-9","volume":"20","author":"PJ Goadsby","year":"2021","unstructured":"Goadsby PJ (2021) Headache research in 2020: disrupting and improving practice. Lancet Neurol 20:7\u20138. https:\/\/doi.org\/10.1016\/S1474-4422(20)30457-9","journal-title":"Lancet Neurol"},{"key":"1700_CR139","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1016\/S0140-6736(20)32162-0","volume":"397","author":"M Ashina","year":"2021","unstructured":"Ashina M, Terwindt GM, Al-Karagholi MA et al (2021) Migraine: Disease characterisation, biomarkers, and precision medicine. Lancet 397:1496\u20131504. https:\/\/doi.org\/10.1016\/S0140-6736(20)32162-0","journal-title":"Lancet"},{"key":"1700_CR140","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1056\/NEJMra1510059","volume":"375","author":"I Ford","year":"2016","unstructured":"Ford I, Norrie J (2016) Pragmatic trials. N Engl J Med 375:454\u2013463. https:\/\/doi.org\/10.1056\/NEJMra1510059","journal-title":"N Engl J Med"},{"key":"1700_CR141","doi-asserted-by":"publisher","first-page":"1099 \u20131115","DOI":"10.1177\/03331024221099035","volume":"42","author":"TJ Schwedt","year":"2022","unstructured":"Schwedt TJ, Tassorelli C, Silberstein SD et al (2022) Guidelines of the International Headache Society for Clinic-Based Headache Registries. Cephalalgia 42:1099\u20131115. https:\/\/doi.org\/10.1177\/03331024221099035","journal-title":"Cephalalgia"},{"issue":"10258","key":"1700_CR142","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1016\/S0140-6736(20)30750-9","volume":"396","author":"GBD 2019 Universal Health Coverage Collaborators","year":"2020","unstructured":"GBD 2019 Universal Health Coverage Collaborators (2020) Measuring universal health coverage based on an index of effective coverage of health services in 204 countries and territories, 1990\u20132019: a systematic analysis for the global burden of Disease Study 2019. Lancet 396(10258):1250\u20131284. https:\/\/doi.org\/10.1016\/S0140-6736(20)30750-9","journal-title":"Lancet"},{"key":"1700_CR143","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1111\/head.13637","volume":"59","author":"PW Chung","year":"2019","unstructured":"Chung PW, Lee MJ, Park JW et al (2019) Differences of Cluster Headache on the basis of sex in the Korean cluster Headache Registry. Headache 59:1722\u20131730. https:\/\/doi.org\/10.1111\/head.13637","journal-title":"Headache"},{"key":"1700_CR144","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1111\/head.13714","volume":"60","author":"CP Hornik","year":"2020","unstructured":"Hornik CP, Gelfand AA, Szperka CL et al (2020) Development of a prospective real-World Data Clinical Registry of children and adolescents with Migraine. Headache 60:405\u2013415. https:\/\/doi.org\/10.1111\/head.13714","journal-title":"Headache"},{"key":"1700_CR145","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1111\/head.13745","volume":"60","author":"TA Pearl","year":"2020","unstructured":"Pearl TA, Dumkrieger G, Chong CD, Dodick DW, Schwedt TJ (2020) Sensory hypersensitivity symptoms in Migraine with vs without aura: results from the American Registry for Migraine Research. Headache 60:506\u2013514. https:\/\/doi.org\/10.1111\/head.13745","journal-title":"Headache"},{"key":"1700_CR146","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9020320","volume":"9","author":"JOT Sipil\u00e4","year":"2020","unstructured":"Sipil\u00e4 JOT, Ruuskanen JO, Rautava P, Kyt\u00f6 V (2020) Adult Migraine Hospital Admission Trends in Finland: a Nationwide Registry Study. J Clin Med 9:320. https:\/\/doi.org\/10.3390\/jcm9020320","journal-title":"J Clin Med"},{"key":"1700_CR147","doi-asserted-by":"publisher","first-page":"1910","DOI":"10.1111\/head.13911","volume":"60","author":"TA Pearl","year":"2020","unstructured":"Pearl TA, Dumkrieger G, Chong CD, Dodick DW, Schwedt TJ (2020) Impact of depression and anxiety symptoms on patient-reported outcomes in patients with migraine: results from the American Registry for Migraine Research (ARMR). Headache 60:1910\u20131919. https:\/\/doi.org\/10.1111\/head.13911","journal-title":"Headache"},{"key":"1700_CR148","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1016\/j.mayocp.2020.06.053","volume":"95","author":"R Ishii","year":"2020","unstructured":"Ishii R, Schwedt TJ, Kim SK, Dumkrieger G, Chong CD, Dodick DW (2020) Effect of Migraine on Pregnancy Planning: Insights From the American Registry for Migraine Research. Mayo Clin Proc 95:2079\u20132089. https:\/\/doi.org\/10.1016\/j.mayocp.2020.06.053","journal-title":"Mayo Clin Proc"},{"key":"1700_CR149","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2020.597881","volume":"11","author":"M Delussi","year":"2020","unstructured":"Delussi M, Gentile E, Coppola G et al (2020) Investigating the effects of COVID-19 Quarantine in Migraine: an observational cross-sectional study from the Italian National Headache Registry (RICe). Front Neurol 11:597881. https:\/\/doi.org\/10.3389\/fneur.2020.597881","journal-title":"Front Neurol"},{"key":"1700_CR150","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1111\/head.14100","volume":"61","author":"M Trivedi","year":"2021","unstructured":"Trivedi M, Dumkrieger G, Chong CD, Dodick DW, Schwedt TJ (2021) Impact of abuse on migraine-related sensory hypersensitivity symptoms: results from the American Registry for Migraine Research. Headache 61:740\u2013754. https:\/\/doi.org\/10.1111\/head.14100","journal-title":"Headache"},{"key":"1700_CR151","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3988\/jcn.2021.17.2.229","volume":"17","author":"PW Chung","year":"2021","unstructured":"Chung PW, Kim BS, Park JW et al (2021) Smoking history and clinical features of Cluster Headache: results from the Korean cluster Headache Registry. J Clin Neurol 17:229\u2013235. https:\/\/doi.org\/10.3988\/jcn.2021.17.2.229","journal-title":"J Clin Neurol"},{"key":"1700_CR152","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s10194-021-01267-x","volume":"22","author":"R Belv\u00eds","year":"2021","unstructured":"Belv\u00eds R, Irimia P, Pozo-Rosich P et al (2021) MAB-MIG: registry of the Spanish neurological society of erenumab for migraine prevention. J Headache Pain 22:74. https:\/\/doi.org\/10.1186\/s10194-021-01267-x","journal-title":"J Headache Pain"},{"key":"1700_CR153","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1177\/03331024211057184","volume":"42","author":"HK Park","year":"2022","unstructured":"Park HK, Chu MK, Oh SY et al (2022) Interim analysis of the Registry for load and management of medication overuse headache (RELEASE): a multicenter, comprehensive medication overuse headache registry. Cephalalgia 42:455\u2013465. https:\/\/doi.org\/10.1177\/03331024211057184","journal-title":"Cephalalgia"},{"key":"1700_CR154","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1111\/head.14311","volume":"62","author":"Z Leibovit-Reiben","year":"2022","unstructured":"Leibovit-Reiben Z, Ishii R, Dodick DW et al (2022) The impact of pre-morbid headaches on headache features and long-term health outcomes following traumatic brain injury: insights from the American Registry for Migraine Research. Headache 62:566\u2013576. https:\/\/doi.org\/10.1111\/head.14311","journal-title":"Headache"},{"key":"1700_CR155","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s10194-022-01447-3","volume":"23","author":"R Ruscheweyh","year":"2022","unstructured":"Ruscheweyh R, Klonowski T, Go\u00dfrau G (2022) The headache registry of the German migraine and Headache Society (DMKG): baseline data of the first 1,351 patients. J Headache Pain 23:74. https:\/\/doi.org\/10.1186\/s10194-022-01447-3","journal-title":"J Headache Pain"},{"issue":"9","key":"1700_CR156","doi-asserted-by":"publisher","first-page":"5725","DOI":"10.1007\/s10072-022-06214-5","volume":"43","author":"P Barbanti","year":"2022","unstructured":"Barbanti P, Egeo G, Aurilia C et al (2022) The first report of the Italian Migraine Registry (I-GRAINE). Neurol Sci 43(9):5725\u20135728. https:\/\/doi.org\/10.1007\/s10072-022-06214-5","journal-title":"Neurol Sci"},{"key":"1700_CR157","volume-title":"Optimizing brain health across the life course: WHO position paper","author":"World Health Organization","year":"2022","unstructured":"World Health Organization (2022) Optimizing brain health across the life course: WHO position paper. World Health Organization, Geneva"},{"key":"1700_CR158","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1016\/S1474-4422(22)00394-5","volume":"21","author":"MO Owolabi","year":"2022","unstructured":"Owolabi MO, Leonardi M, Bassetti C et al (2022) The neurology revolution. Lancet Neurol 21:960\u2013961. https:\/\/doi.org\/10.1016\/S1474-4422(22)00394-5","journal-title":"Lancet Neurol"},{"key":"1700_CR159","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/S1474-4422(22)00266-6","volume":"21","author":"The Lancet Neurology","year":"2022","unstructured":"The Lancet Neurology (2022) WHO launches its global action plan for brain health. Lancet Neurol 21:671. https:\/\/doi.org\/10.1016\/S1474-4422(22)00266-6","journal-title":"Lancet Neurol"}],"container-title":["The Journal of Headache and Pain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10194-023-01700-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s10194-023-01700-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10194-023-01700-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,4]],"date-time":"2024-01-04T10:05:08Z","timestamp":1704362708000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejournalofheadacheandpain.biomedcentral.com\/articles\/10.1186\/s10194-023-01700-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,4]]},"references-count":159,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1700"],"URL":"https:\/\/doi.org\/10.1186\/s10194-023-01700-3","relation":{},"ISSN":["1129-2377"],"issn-type":[{"value":"1129-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,4]]},"assertion":[{"value":"10 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"ML: Associate Editor of The Journal of Headache and Pain. PM: Editor-in-Chief of The Journal of Headache and Pain and of SN Comprehensive Clinical Medicine; EU Expert, European Medicines Agency. RB: research support from the NIH, Allergan, Teva, Dr. Ready, Eli Lilly, Trigeminal and the Migraine Research Foundation. He is a reviewer for NINDS, holds stock options in AllayLamp, Theranica and Percept; serves as consultant, advisory board member, or has received honoraria from Alder, Allergan, Amgen, Autonomic Technologies, Avanir, Biohaven, CGRP diagnostic, Dr. Reddy\u2019s Laboratory, ElectroCore, Eli Lilly, GlaxoSmithKline, Merck, Pernix, Theranica, Teva, and Trigemina; CME fees from Healthlogix, Medlogix, WebMD\/Medscape, and Patents 9061025, 11732265.1, 10806890, US2021-0015908, WO21007165, US2021-0128724, WO21005497. LG: consultancy and advisory fees from Abbvie-AllerganSpA, Lundbeck, Novartis, EliLilly, TEVA Pharm, Pfizer. AG: Elected Trustee, World Federation of Neurology; Treasurer, International League against Epilepsy; Board member: Neurological Sciences (associate editor), European Journal of Neurology, Epilepsy and Behavior, Journal of Neurological Sciences. RL: has received research support from the National Institutes of Health, the FDA, and the National Headache Foundation. He serves as consultant, advisory board member, or has received honoraria or research support from AbbVie\/Allergan, Amgen, Biohaven, Dr. Reddy\u2019s Laboratories (Promius), electroCore, Eli Lilly, GlaxoSmithKline, Lundbeck, Merck, Novartis, Teva, Vector, and Vedanta Research. He receives royalties from Wolff\u2019s Headache, 8th edition (Oxford University Press, 2009), and Informa. He holds stock in Biohaven and Manistee. DDM: honoraria, research, and travel grants from Allergan\/Abbvie, Amgen, Biogen, Cefaly, Genesis Pharma, Eli Lilly, Electrocore, Lundbeck, Mertz, Merk-Serono, Novartis, Roche, Sanofi, Specifar, and Teva; he participated in clinical trials for Amgen, Novartis, Cefaly, Eli Lilly, Electrocore, Genesis Pharma, Lundbeck, Mertz, Specifar, and Teva as principal investigator; he is President of the Hellenic Headache Society and Co-chairman of the Headache Scientific Panel at the European Academy of Neurology. JO: stock owner in Cephagenix and Lundbeck. SS: personal fees as speaker or advisor by Abbott, Allergan-Abbvie, AstraZeneca, Boheringer, Eli Lilly, Lundbeck, Novartis, NovoNordisk, Pfizer, Teva; research grants by Novartis, Uriach; president elect European Stroke Organization, second vice president of the European Headache Federation, specialty chief editor in Headache and Neurogenic Pain for Frontiers in Neurology, associate editor for The Journal of Headache and Pain, assistant editor for Stroke. TJS: Director of the Global Campaign against Headache. NS: Chairman, Surya Neuro Center; Founder Trustee & Chairman, Epilepsy Foundation India; Fellow, Indian Academy of Neurology; Member, Academy of Medical Sciences; Fellow, American Academy of Neurology; President, Indian Federation Of Neuro - Rehabilitation (IFNR); Regional Vice President, World Federation Neuro-Rehabilitation (WFNR); Past President, Indian Academy of Neurology (IAN); President Elect, Indian Stroke Association (ISA); Chair, Developing World Forum; President Elect, Asian Oceanian Society of Neurorehabilitation (AOSNR); Chair, Telemedicine Academy Indian Confederation For Healthcare Accreditation (ICHA); Member, Digital Strategy Subcommittee (DSS) American Academy of Neurology (AAN 2021-2023); President, WCNR2018Mumbai; Treasurer, Indian Academy of Neurology (IAN) 2014-2020; Executive Member, Indian Stroke Association (2018-2021); Past President, Bombay Neurosciences Association; Past President, Maharastra Association of Neurology. TT: Takao Takeshima is a consultant\/advisor for Hedgehog MedTech and Sawai, and has received speaker honoraria from Eli Lilly, Daiichi Sankyo, Otsuka, Amgen. CT: honoraria for the participation in advisor boards or for speaking in scientific symposia from Allergan\/Abbvie, Domp\u00e9, Eli Lilly, Novartis, Lundbeck, Pfizer, Biohaven, Teva, WebMD; research support from AbbVie, Domp\u00e9, Migraine Research Foundation, Italian Ministry of Health, EU Commission; payments for Clinical trials from Allergan\/Abbvie, Amgen, Lilly, Novartis, Lundbeck, Pfizer, Biohaven and Teva; she is President of the International Headache Society and co-sponsor of the initiative \u2018Headache research Priorities\u2019 in collaboration with AHS. S-JW: honoraria as a moderator from AbbVie, Pfizer, Eli Lilly and Biogen; PI in trials sponsored by AbbVie, Novartis, Eli Lilly and Lundbeck; Research grants from the Taiwan National Science and Technology Council, Brain Research Center, National Yang Ming Chiao Tung University from The Featured Areas Research Center Program within the framework of the Higher Education Sprout Project by the Ministry of Education (MOE) in Taiwan, Taipei Veterans General Hospital, Taiwan Headache Society and Taiwan branches of Eli Lillyand Novartis. AR: editorial board member of The Journal of Headache and Pain. AF, MOO, ERdlT, and TW declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4"}}